CDKN2A, encoding the tumor suppressors p16 and p14ARF, is one of the most frequently homozygously deleted genes across all human cancers (Mulvaney, 2023), and acts as an inhibitor of cuproptosis. This evidence concerns the gene CDKN2A and cancer.